High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts. 1985

J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty

Tumor imaging and biodistribution of an indium-labeled monoclonal antibody (MAB) to carcinoembryonic antigen (CEA) [anti-CEA MAB-diethylenetriaminepentaacetic acid (DTPA)-111In] have been investigated using LS174T human colon cancer xenografts in nude mice. Antibody specificity, dose, and specific activity were examined with respect to tumor uptake and quality of scintiscans at different times following injection. The CEA-bearing LS174T tumors were imaged specifically with anti-CEA MAB-DTPA-111In. Using 62.5 ng of indium-labeled MAB (50 microCi/micrograms) the ratio of activity in tissue expressed as a percentage of the total radioactive dose injected into the animal per gram tissue for tumor:blood increased from 0.66 +/- 0.02 (SE) at 1 h to 14.8 +/- 1.1 at 72 h. Scintiscan quality improved with the rise in tumor:blood ratio until 48 h. At longer intervals insufficient counts remained for imaging. The tumor:blood ratio and the scintiscan quality were not improved by increasing the MAB dose to 625 or 6250 ng but good images were obtained at longer times postinjection. By decreasing the 111In from 50 to 10 microCi/micrograms of MAB, the unbound 111In was decreased from 7 microCi/micrograms (14%) to 0.2 microCi/micrograms (2%). Even with the lower specific activity (9.8 microCi/micrograms) of the 10-microCi/micrograms preparation, scintiscan quality at the 62.5-ng dose was maintained. This anti-CEA MAB-DTPA-111In preparation was stable, retained immunological activity, did not require column chromatography to remove unbound 111In, was specific for a CEA-bearing tumor, and was effective for tumor imaging over a wide range of antibody doses (3 to 300 micrograms MAB/kg body weight). This anti-CEA MAB-DTPA-111In preparation is feasible and practical for imaging CEA-bearing tumors in humans.

UI MeSH Term Description Entries
D007204 Indium A metallic element, atomic number 49, atomic weight 114.818, symbol In. It is named from its blue line in the spectrum.
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011868 Radioisotopes Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Daughter Isotope,Daughter Nuclide,Radioactive Isotope,Radioactive Isotopes,Radiogenic Isotope,Radioisotope,Radionuclide,Radionuclides,Daughter Nuclides,Daugter Isotopes,Radiogenic Isotopes,Isotope, Daughter,Isotope, Radioactive,Isotope, Radiogenic,Isotopes, Daugter,Isotopes, Radioactive,Isotopes, Radiogenic,Nuclide, Daughter,Nuclides, Daughter
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004369 Pentetic Acid An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium. DTPA,Diethylenetriamine Pentaacetic Acid,Pentetates,Penthanil,Ca-DTPA,CaDTPA,CaNa-DTPA,Calcium Trisodium Pentetate,DETAPAC,Indium-DTPA,Mn-Dtpa,Pentacin,Pentacine,Pentaind,Pentetate Calcium Trisodium,Pentetate Zinc Trisodium,Sn-DTPA,Zinc-DTPA,Indium DTPA,Pentaacetic Acid, Diethylenetriamine,Pentetate, Calcium Trisodium,Zinc DTPA
D005260 Female Females

Related Publications

J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
March 1989, Cancer research,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
July 1989, Zhonghua zhong liu za zhi [Chinese journal of oncology],
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
June 1993, Cancer research,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
December 1992, Cancer,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
December 1986, Cancer research,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
July 1993, Kaku igaku. The Japanese journal of nuclear medicine,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
February 1997, Cancer biotherapy & radiopharmaceuticals,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
December 1986, Cancer research,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
February 1990, Cancer research,
J G Jakowatz, and B G Beatty, and W G Vlahos, and D Porudominsky, and V J Philben, and L E Williams, and R J Paxton, and J E Shively, and J D Beatty
March 1992, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
Copied contents to your clipboard!